Alpha Therapy, LLC Lantheus, a 10% owner of $CATX, sold 80,783 shares of the company on 09-03-2026 for an estimated $250,895. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.7% of their shares of this class of stock. Following this trade, they now own 11,440,513 shares of this class of $CATX stock.
$CATX Insider Trading Activity
$CATX insiders have traded $CATX stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $CATX stock by insiders over the last 6 months:
- ALPHA THERAPY, LLC LANTHEUS has made 0 purchases and 5 sales selling 403,975 shares for an estimated $1,265,350.
- HOLDINGS, INC. LANTHEUS has made 0 purchases and 2 sales selling 113,914 shares for an estimated $357,183.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CATX Hedge Fund Activity
We have seen 84 institutional investors add shares of $CATX stock to their portfolio, and 67 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- OPALEYE MANAGEMENT INC. removed 4,675,000 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $15,941,750
- BLACKROCK, INC. added 4,145,591 shares (+77.5%) to their portfolio in Q2 2026, for an estimated $14,136,465
- CITADEL ADVISORS LLC added 3,296,013 shares (+1218.5%) to their portfolio in Q1 2026, for an estimated $13,744,374
- STATE STREET CORP added 2,919,101 shares (+93.2%) to their portfolio in Q2 2026, for an estimated $9,954,134
- PATIENT SQUARE CAPITAL LP removed 1,625,000 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $5,541,250
- MORGAN STANLEY removed 1,070,792 shares (-35.9%) from their portfolio in Q2 2026, for an estimated $3,651,400
- SPRUCE STREET CAPITAL LP added 1,066,824 shares (+40.6%) to their portfolio in Q2 2026, for an estimated $3,637,869
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CATX Price Targets
Multiple analysts have issued price targets for $CATX recently. We have seen 6 analysts offer price targets for $CATX in the last 6 months, with a median target of $13.0.
Here are some recent targets:
- David Nierengarten from Wedbush set a target price of $11.0 on 05/05/2026
- Robert Burns from HC Wainwright & Co. set a target price of $13.0 on 03/23/2026
- David Dai from UBS set a target price of $8.0 on 03/18/2026
- Yuan Zhi from B. Riley Securities set a target price of $13.0 on 03/18/2026
- Jeet Mukherjee from BTIG set a target price of $14.0 on 03/17/2026
- Leonid Timashev from RBC Capital set a target price of $14.0 on 03/17/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
